Keywords: swissmedic, approves, sanofi-aventis, acomplia, swiss, drug, regulatory

Swissmedic approves Sanofi-Aventis' Acomplia

Article | 09 April 2007

The Swiss drug regulatory body Swissmedic has approved the marketing of French drug major Sanofi-Aventis' obesity drug Acomplia (rimonabant) The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Go to company listing